Purity Independent Subtyping of Tumors (PurIST), a clinically robust, single sample classifier for tumor subtyping in pancreatic cancer

PURPOSE: Molecular subtyping for pancreatic cancer has made substantial progress in recent years, facilitating the optimization of existing therapeutic approaches to improve clinical outcomes in pancreatic cancer. With advances in treatment combinations and choices, it is becoming increasingly impor...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clin Cancer Res
Hauptverfasser: Rashid, Naim U, Peng, Xianlu L., Jin, Chong, Moffitt, Richard A., Volmar, Keith E., Belt, Brian A., Panni, Roheena Z., Nywening, Timothy M., Herrera, Silvia G., Moore, Kristin J., Hennessey, Sarah, Morrison, Ashley B., Kawalerski, Ryan, Nayyar, Apoorve, Chang, Audrey E., Schmidt, Benjamin, Kim, Hong Jin, Linehan, David C., Yeh, Jen Jen
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2019
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6942634/
https://ncbi.nlm.nih.gov/pubmed/31754050
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-1467
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge